The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 18347976)

Published in Glycoconj J on March 18, 2008

Authors

José Manuel Gómez1, Ramon Vila, Pablo Catalina, Juan Soler, Lina Badimón, Manel Sahún

Author Affiliations

1: Department of Endocrinology and Nutrition, University Hospital of Bellvitge, Barcelona, Spain. jmgs@csub.scs.es

Articles cited by this

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet (1992) 11.50

Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A (2003) 6.06

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA (2004) 3.69

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes (2002) 3.59

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes (2002) 2.73

Endothelial function: a critical determinant in atherosclerosis? Circulation (2004) 2.71

Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care (1998) 2.14

The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects. Diabetologia (2000) 2.14

Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism (2002) 1.68

Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation (2004) 1.59

Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation (2000) 1.59

Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia (1995) 1.54

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2005) 1.40

Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ (1996) 1.35

CRP as a mediator of disease. Circulation (2004) 1.31

Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care (2003) 1.27

Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism (2005) 1.23

Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia (2004) 1.21

Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int J Cardiol (2005) 1.03

Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord (2004) 1.03

Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol (2004) 1.01

Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study. Metabolism (2006) 0.98

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care (1999) 0.97

Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J (2005) 0.94

Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern Med (2005) 0.93

Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training. Metabolism (2006) 0.92

Cell adhesion molecules in cardiovascular disease and its risk factors--what can soluble levels tell us? J Clin Endocrinol Metab (2000) 0.92

Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler Thromb Vasc Biol (2005) 0.89

Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels. Diabetologia (2000) 0.88

Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes (1997) 0.87

Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus. Thromb Res (2006) 0.85

Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C. Diabet Med (2004) 0.84

Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial. Cardiovasc Diabetol (2003) 0.84

Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabet Med (1996) 0.83

Higher carotid-radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes. Diabet Med (2004) 0.82

Elevated soluble cell adhesion molecules E-selectin and intercellular cell adhesion molecule-1 in type-2 diabetic patients with and without asymptomatic peripheral arterial disease. Int Angiol (2004) 0.82

Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease. Diabet Med (2005) 0.80

Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease. Int Angiol (2004) 0.80

The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with Type 2 diabetes mellitus. Diabet Med (2002) 0.80

Elevation of E-selectin concentrations may correlate with potential endothelial dysfunction in individuals with hypopituitarism during therapy with growth hormone. Curr Neurovasc Res (2007) 0.75

Increased prothrombin fragment 1 + 2 and D-dimer in first-degree relatives of type 2 diabetic patients. Prethrombotic state in relatives of type 2 diabetic patients. Acta Diabetol (1996) 0.75

Articles by these authors

Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine (2010) 1.24

The management of aortic stent-graft infection: endograft removal versus conservative treatment. Ann Vasc Surg (2010) 0.96

Guidelines for translational research in heart failure. J Cardiovasc Transl Res (2015) 0.95

Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin Endocrinol (Oxf) (2003) 0.92

Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin. Metabolism (2005) 0.88

The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res (2004) 0.87

Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg (2008) 0.87

Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. Obes Surg (2003) 0.82

Simultaneous inhibition of TXA(2) and PGI(2) synthesis increases NO release in mesenteric resistance arteries from cirrhotic rats. Clin Sci (Lond) (2010) 0.82

Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART). Lipids Health Dis (2011) 0.80

D-dimer local expression is increased in symptomatic patients undergoing carotid endarterectomy. Int J Cardiol (2006) 0.79

[Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going?]. Rev Esp Cardiol (2010) 0.79

Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency. Clin Endocrinol (Oxf) (2006) 0.78

A folate-rich diet is as effective as folic acid from supplements in decreasing plasma homocysteine concentrations. Int J Med Sci (2005) 0.77

Elevation of E-selectin concentrations may correlate with potential endothelial dysfunction in individuals with hypopituitarism during therapy with growth hormone. Curr Neurovasc Res (2007) 0.75

[Study of the relationship between adiponectin, interleukin-18, ghrelin and bone mineral density in morbidly obese women after gastric bypass]. Endocrinol Nutr (2009) 0.75

Modeling Hedgehog Signaling Through Flux-Saturated Mechanisms. Methods Mol Biol (2015) 0.75

Giant cell arteritis presenting as dysarthria and mediastinal mass. Interact Cardiovasc Thorac Surg (2010) 0.75

Role of ultrasound arterial mapping in planning therapeutic options for critical ischemia of lower limbs in diabetic patients. Ann Vasc Surg (2012) 0.75

Hypothalamic-pituitary sarcoidosis with hypopituitarism. Long-term remission with methylprednisolone pulse therapy. Pituitary (2002) 0.75